UBS Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-402,893
| Closed | -$1.69M | – | 9137 |
|
|
2023
Q1 | $1.69M | Sell |
402,893
-523,416
| -57% | -$2.2M | ﹤0.01% | 2739 |
|
|
2022
Q4 | $5.57M | Buy |
926,309
+782,053
| +542% | +$4.7M | ﹤0.01% | 1753 |
|
|
2022
Q3 | $840K | Sell |
144,256
-133,244
| -48% | -$776K | ﹤0.01% | 2985 |
|
|
2022
Q2 | $1.66M | Buy |
277,500
+260,766
| +1,558% | +$1.56M | ﹤0.01% | 2521 |
|
|
2022
Q1 | $78K | Buy |
16,734
+12,717
| +317% | +$59.3K | ﹤0.01% | 5086 |
|
|
2021
Q4 | $10K | Sell |
4,017
-261
| -6% | -$650 | ﹤0.01% | 7748 |
|
|
2021
Q3 | $13K | Sell |
4,278
-2,469
| -37% | -$7.5K | ﹤0.01% | 6589 |
|
|
2021
Q2 | $17K | Sell |
6,747
-3,224
| -32% | -$8.12K | ﹤0.01% | 6455 |
|
|
2021
Q1 | $29K | Buy |
9,971
+5,693
| +133% | +$16.6K | ﹤0.01% | 6045 |
|
|
2020
Q4 | $14K | Sell |
4,278
-584
| -12% | -$1.91K | ﹤0.01% | 6237 |
|
|
2020
Q3 | $10K | Sell |
4,862
-21,000
| -81% | -$43.2K | ﹤0.01% | 6026 |
|
|
2020
Q2 | $30K | Buy |
25,862
+8,195
| +46% | +$9.51K | ﹤0.01% | 5445 |
|
|
2020
Q1 | $16K | Buy |
17,667
+8,263
| +88% | +$7.48K | ﹤0.01% | 5754 |
|
|
2019
Q4 | $15K | Buy |
9,404
+5,328
| +131% | +$8.5K | ﹤0.01% | 6006 |
|
|
2019
Q3 | $3K | Sell |
4,076
-4,109
| -50% | -$3.02K | ﹤0.01% | 6736 |
|
|
2019
Q2 | $7K | Buy |
8,185
+2,255
| +38% | +$1.93K | ﹤0.01% | 6417 |
|
|
2019
Q1 | $6K | Sell |
5,930
-26,451
| -82% | -$26.8K | ﹤0.01% | 6297 |
|
|
2018
Q4 | $24K | Buy |
32,381
+6,576
| +25% | +$4.87K | ﹤0.01% | 5739 |
|
|
2018
Q3 | $56K | Buy |
25,805
+5,398
| +26% | +$11.7K | ﹤0.01% | 5199 |
|
|
2018
Q2 | $101K | Buy |
20,407
+5,252
| +35% | +$26K | ﹤0.01% | 4560 |
|
|
2018
Q1 | $59K | Buy |
15,155
+3,979
| +36% | +$15.5K | ﹤0.01% | 4750 |
|
|
2017
Q4 | $30K | Buy |
11,176
+3,973
| +55% | +$10.7K | ﹤0.01% | 5288 |
|
|
2017
Q3 | $23K | Buy |
7,203
+2,865
| +66% | +$9.15K | ﹤0.01% | 5470 |
|
|
2017
Q2 | $14K | Sell |
4,338
-479
| -10% | -$1.55K | ﹤0.01% | 5640 |
|
|
2017
Q1 | $20K | Sell |
4,817
-3,867
| -45% | -$16.1K | ﹤0.01% | 5240 |
|
|
2016
Q4 | $35K | Sell |
8,684
-532
| -6% | -$2.14K | ﹤0.01% | 5200 |
|
|
2016
Q3 | $34K | Buy |
9,216
+7,791
| +547% | +$28.7K | ﹤0.01% | 4958 |
|
|
2016
Q2 | $5K | Buy |
1,425
+1,319
| +1,244% | +$4.63K | ﹤0.01% | 6283 |
|
|
2016
Q1 | $1K | Sell |
106
-965
| -90% | -$9.1K | ﹤0.01% | 6656 |
|
|
2015
Q4 | $13K | Buy |
1,071
+935
| +688% | +$11.3K | ﹤0.01% | 5883 |
|
|
2015
Q3 | $2K | Hold |
136
| – | – | ﹤0.01% | 6651 |
|
|
2015
Q2 | $3K | Sell |
136
-4,369
| -97% | -$96.4K | ﹤0.01% | 6506 |
|
|
2015
Q1 | $81K | Buy |
4,505
+3,538
| +366% | +$63.6K | ﹤0.01% | 4321 |
|
|
2014
Q4 | $23K | Buy |
+967
| New | +$23K | ﹤0.01% | 5425 |
|